Summary
A federal report, as detailed in the American Medical Association's (AMA) March 13, 2026, Advocacy Update, reveals that health insurers continue to fail in complying with mental health and substance use disorder (MH/SUD) parity laws. These violations include imposing restrictive prior authorizations and excluding treatments such as methadone. This ongoing non-compliance has led to significant fines and legal actions against insurers across various states.
Key Takeaways
- Health insurers are reportedly failing to comply with federal mental health parity laws, according to a recent federal report.
- Violations include restrictive prior authorizations and the exclusion of treatments like methadone.
- States are increasingly taking enforcement action, with Georgia issuing nearly $25 million in fines to insurers.
- New federal rules aim to strengthen MHPAEA by improving network adequacy and reducing prior authorization requirements.
- Advocacy groups like the AMA are pushing for greater accountability and enforcement to ensure equitable access to mental health and substance use disorder care.
Balanced Perspective
A federal report indicates that health insurers are still not fully compliant with the Mental Health Parity and Addiction Equity Act (MHPAEA). This non-compliance manifests in various ways, such as restrictive treatment limitations and exclusions. While regulatory bodies and advocacy groups are actively working to address these issues through new rules and enforcement, the persistent nature of these violations suggests a complex challenge in achieving full parity in practice. The effectiveness of current and future interventions remains to be seen.
Optimistic View
The increasing scrutiny and enforcement actions, including substantial fines levied by states like Georgia, signal a positive shift towards greater accountability for insurers. The recent final rules from the Departments of Health and Human Services, Labor, and Treasury, aimed at strengthening MHPAEA, are expected to improve network composition and reduce prior authorization burdens. This proactive regulatory environment, coupled with advocacy efforts from organizations like the AMA, offers hope for a future where access to mental health and substance use disorder care is truly on par with physical health.
Critical View
Despite the existence of MHPAEA and subsequent regulatory updates, the persistent failures of health insurers to provide equitable coverage for mental health and substance use disorder treatments are deeply concerning. The continued use of restrictive practices like prior authorizations and treatment exclusions, as highlighted in the federal report, suggests that systemic issues within the insurance industry may be deeply entrenched. This ongoing non-compliance risks further exacerbating the mental health crisis and widening disparities in care access, particularly for vulnerable populations.
Source
Originally reported by ama-assn.org